期刊文献+

浅谈PSUR制度对我国药品不良反应报告制度的启示 被引量:4

The PSUR System to the Implications of Chinese Adverse Drug Reaction Reporting System
下载PDF
导出
摘要 通过对国际通行的药品安全性更新报告(PSUR)制度相关规定及其特点进行分析,提出我国推广和完善PSUR制度的意义,为完善我国药品不良反应报告制度、加强药品上市后的安全监管、保障公众的用药安全提供服务。 By analyzing the relevant provisions of descriptions and characteristics of the PSUR system,included the background and significance of the PUSR development,the contents of the requirements and data sources,the frequency of reporting and the main responsibility. It recommend that China should improve and promote the PSUR system,as to be a complement of Chinese adverse reaction reporting system,while clarified its main reporting and improved enterprise on a regular basis to report adverse reactions and sense of responsibility.
出处 《中国药物警戒》 2010年第6期353-355,共3页 Chinese Journal of Pharmacovigilance
关键词 上市后安全监管 不良反应报告 药品安全性更新报告 post-market drug safety supervision adverse reaction reports Periodic Safety Update Report(PSUR)
  • 相关文献

参考文献6

  • 1EMEA.Clinical Safety Data Management:Periodic Safety Update Reports for Marketed Drugs E2C(R1)[EB/OL].[2010-01-03]http: //www.emea.europa.eu/pd fs/human/ich/028895en.pdf.
  • 2FDA.E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting[EB/OL].[2010-01-03]http:// www.fda.gov/Regulatorylnformation/Guidances/ucm129457.htm.
  • 3EMEA施行提交定期安全性更新报告的新法规[J].中国药物警戒,2006,3(3):189-190. 被引量:1
  • 4FDA.Guidance for Industry Addendum to E2C Clinical Safety Data Management:Periodic Safety Update Reports for Marketed Drugs [EB/OL]. [2010-01-03]http://www.fda.gov/downloads/Regulatory- Information/Guidances/UCM129455.pdf.
  • 5业内资讯:药企、药店、医院有责任上报药品不良反应[EB/OL].2009-7-9[2010-01-03].http://www.dlhospital.com/sy/ynzxmx.asp?sh=193.
  • 6国家食品药品监督管理局国家食品药品监督管理局7月例行新闻发布会[EB/OL].2008-07-08[2010-01-03].http://www.sda.gov.cn/WS01/CL0329/31453.html.

同被引文献44

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部